Doxycycline desensitization in chronic Q fever-A critical tool for the clinician.

IDCases

Infectious Diseases Unit, Bnai-Zion Medical Center, Sderot Eliyahu Golomb 47, Haifa Affiliated with Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Published: February 2018

We present the case of a 45 year old woman with acute Q fever pneumonia who progressed to the chronic phase of the disease despite azithromycin therapy. A trial of doxycycline was halted because of severe allergy and she was put on clarithromycin and later moxifloxacin. Failure of both drugs required desensitization to doxycycline with escalating doses. After two-year treatment with doxycycline-hydroxychloroquine combination, complete recovery was declared. Our case highlights the option of doxycycline desensitization when an acute allergic reaction poses an obstacle to optimal treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881519PMC
http://dx.doi.org/10.1016/j.idcr.2018.01.006DOI Listing

Publication Analysis

Top Keywords

doxycycline desensitization
8
doxycycline
4
desensitization chronic
4
chronic fever-a
4
fever-a critical
4
critical tool
4
tool clinician
4
clinician case
4
case 45 year
4
45 year woman
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!